RIGEL PHARMACEUTIC revenue breakdown overview

RIGEL PHARMACEUTIC revenue for the last year amounted to 162.82 M CHF, the most of which — 162.82 M CHF — came from its highest performing source at the moment, Novel Therapies, the year earlier bringing 98.41 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought RIGEL PHARMACEUTIC 162.82 M CHF, and the year before that — 98.41 M CHF.